4//SEC Filing
Krebs Stephanie 4
Accession 0001415889-25-004229
CIK 0001829802other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:06 PM ET
Size
5.7 KB
Accession
0001415889-25-004229
Insider Transaction Report
Form 4
Krebs Stephanie
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-02-14+120,000→ 120,000 totalExercise: $0.48Exp: 2035-02-13→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option shall vest over a period of four years as follows: 25% of the total number of shares subject to the option shall vest on February 14, 2026, and the remainder will vest 1/48th of total number of shares subject to the option monthly thereafter over the remaining three years, subject to the Reporting Person's continuous service with the Issuer as of each such date.
Documents
Issuer
Sensei Biotherapeutics, Inc.
CIK 0001829802
Entity typeother
Related Parties
1- filerCIK 0001998150
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:06 PM ET
- Size
- 5.7 KB